Study Participant Receives NIAID/GSK Candidate Ebola Vaccine
September 4, 2014 — A 26-year-old man, the third participant enrolled in VRC 207, receives a dose of the investigational NIAID/GSK Ebola vaccine at the NIH Clinical Center in Bethesda, Md. Credit: NIAID